Oncoscope is an AI-enhanced oncology evidence and decision-support platform. Its core goal is to bring the latest oncology evidence into clinical and research decision-making in the right format and at the right time. The official website emphasizes that it is powered by a single database and is divided into three product tiers for different levels of care and decision-making: Essential, Edge, and Enterprise.
Essential is aimed at physicians who want to improve individualized treatment decisions. It provides individualized treatment paths, concise research data, downloadable SLR protocols, conference updates, and weekly email updates. Edge is designed for academic leaders and specialists; on top of Essential, it adds interactive disease maps, Living OncoLibrary, review and enrichment of pre-extracted research data, custom institution solutions, and on-demand summary reports. Enterprise is aimed at pharmaceutical innovators and is planned to offer an SLR report suite, a Living SLR report portal, strategic value frameworks, conference highlights slides, and PICO mapping / prioritization.
The page does not disclose specific pricing. It only states that users can βRequest free access,β with free access limited to verified healthcare professionals. Note that the Custom institution solution in Edge is not included in free access. Enterprise is still marked as Coming Soon, so enterprise-level features and procurement details are not yet complete.
Its strengths lie in its vertical focus on oncology, covering clinical treatment pathways, research evidence organization, conference developments, and SLR use cases. The combination of AI enhancement and human-driven curation should be valuable for physicians and academic experts. The downside is that the official website does not provide key enterprise software details such as third-party integrations, permission management, data security and compliance, deployment options, or APIs. Pricing transparency is also limited.
Oncoscope is better suited for oncologists, specialist researchers, academic teams at medical institutions, and pharmaceutical companies focused on oncology pipelines and market insights. Access from mainland China cannot be determined from the main content, and payment methods are not disclosed. If stable access is not available, UpToDate, NCCN/ESMO guidelines, ClinicalKey, or local medical databases can be used as alternatives or supplements.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on oncoscope.com official site.
oncoscope.com is an Unknown SaaS Tools provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach oncoscope.com directly.